These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6990991)

  • 41. Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting.
    Ginsberg H; Davidson N; Le NA; Gibson J; Ahrens EH; Brown WV
    Biochim Biophys Acta; 1982 Aug; 712(2):250-7. PubMed ID: 7126604
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
    Leijd B
    Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
    Sale JK; Johnstone JH
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N; Cloarec M; Jacotot B
    Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevation of high density lipoprotein cholesterol (cHDL) and reduction of the total cholesterol/cHDL index in the treatment of hyperlipoproteinaemias IIb and IV with bezafibrate.
    Neuman MP; Kurlat MI; Neuman J
    Curr Med Res Opin; 1983; 8(5):358-67. PubMed ID: 6839800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoprotein protein receptors and their relation to atherosclerosis.
    Nestel PJ
    Circ Res; 1980 Jun; 46(6 Pt 2):I106-9. PubMed ID: 6991149
    [No Abstract]   [Full Text] [Related]  

  • 50. CI-924 effects on plasma lipids in patients with type II and type IV hyperlipoproteinaemia.
    Corder CN; Kloer HU; Price MD
    Eur J Clin Pharmacol; 1989; 37(5):477-81. PubMed ID: 2598985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.
    Stewart JM; Packard CJ; Lorimer AR; Boag DE; Shepherd J
    Atherosclerosis; 1982 Sep; 44(3):355-65. PubMed ID: 6293516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):48-51. PubMed ID: 4060509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism.
    Nikkilä EA; Taskinen MR; Sane T
    Am Heart J; 1987 Feb; 113(2 Pt 2):543-8. PubMed ID: 3544769
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose.
    Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T
    Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of fibronectin to human lipoproteins.
    Cseh K; Karadi I; Rischak K; Szollar L; Janoki G; Jakab L; Romics L
    Clin Chim Acta; 1989 Jun; 182(1):75-85. PubMed ID: 2502332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of effect of tocopherol on plasma lipids and lipoproteins in man.
    Kesaniemi YA; Grundy SM
    Am J Clin Nutr; 1982 Aug; 36(2):224-8. PubMed ID: 7102581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia].
    Nowicka G; Kłosiewicz-Latoszek L
    Wiad Lek; 1985 Aug; 38(16):1179-84. PubMed ID: 4082589
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential distribution of sphingomyelins among plasma lipoprotein classes.
    Myher JJ; Kuksis A; Breckenridge WC; Little JA
    Can J Biochem; 1981 Aug; 59(8):626-36. PubMed ID: 7296345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins.
    Alaupovic P
    Can J Biochem; 1981 Aug; 59(8):565-79. PubMed ID: 7028220
    [No Abstract]   [Full Text] [Related]  

  • 60. Very low density lipoprotein (VLDL) pattern in primary hyperlipoproteinaemia type IIb and type IV.
    Kłosiewicz-Latoszek L; Naruszewicz M; Cybulska B; Szostak WB; Chotkowska E
    Mater Med Pol; 1979; 11(3):230-4. PubMed ID: 232894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.